Name: Recombinant Parvovirus VLP VP1
Price: Inquiry

- Overview
  - Recombinant Parvovirus B19 VLP VP1 produced in e.coli contains 227 amino acids from the N-terminus of VP1 protein sequence. Parvovirus B19 VLP VP1/VP2 is purified by proprietary chromatographic techniques. The B19 virus, usually referred to as parvovirus B19 or sometimes as erythrovirus B19, belongs to the family of parvoviruses, genus erythrovirus. B19 virus causes a childhood rash named 'fifth disease' or 'erythema infectiosum' which is ordinarily known as 'slapped cheek syndrome'. Erythroviruses are members of the Parvoviridae family of small DNA viruses. The B19 virus is a non-enveloped, icosahedral virus which contains a single-stranded linear DNA genome. Parvovirus B19 is classified as erythrovirus because of its capability to invade red blood cell precursors in the bone marrow. This virus is mainly spread by infected respiratory droplets; though, blood-borne transmission has also been reported.
    
    Please contact us at for specific academic pricing.
- Properties
  - Source
    
    E. coli
    
    Type
    
    Recombinant Proteins
    
    Purification
    
    Greater than 90.0% as determined by 12% PAGE (coomassie staining).
    
    Formulation
    
    Parvovirus B19 VLP VP1 protein solution is supplied in PBS pH 7.4 and 0.02% Sodium azide.
    
    Storage
    
    Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. Avoid multiple freeze-thaw cycles.
    
    * For Research Use Only. Not for use in diagnostic/therapeutics procedures.

Recombinant Parvovirus VLP VP1

Recombinant Parvovirus VLP VP1

We Also Recommend

Recombinant Hemagglutinin-Influenza A Virus H1N1 California 04/2009

Recombinant Hemagglutinin-Influenza A Virus H5N1 Indonesia 05/2005

Recombinant Hemagglutinin-Influenza A Virus H7N7 Netherlands 219/03